Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.